Mark Nagel - Concepedia

Author

Mark Nagel

Trudell Medical International (Canada)

Also Known As

M NAGEL, M Nagel, M. Nagel, M. W. NAGEL, M. W. Nagel, M.W. NAGEL, M.W. Nagel, MARK NAGEL, MARK W. NAGEL, Mark Nagel

123

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Trudell Medical International (Canada)Gilead Sciences (United States)GlaxoSmithKline (United States)Hospital for Sick Children University of Toronto

About

Mark Nagel is an author at Trudell Medical International (Canada) specializing in medicine, measurement, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	398
2	Engineering	6	6	282
3	Allergy	2	2	85
4	Business	1	1	71
5	Education	1	1	36

Mark Nagel

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
ANGPTL3 Stimulates Endothelial Cell Adhesion and Migration via Integrin αvβ3 and Induces Blood Vessel Formation in Vivo Gieri Camenisch, M. Teresa Pisabarro, Daniel Sherman, Journal of Biological Chemistry	2002	249
Human Platelets as a Model for the Binding and Degradation of Thrombopoietin Paul J. Fielder, Philip E. Hass, Mark Nagel, Blood	1997	141
Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: Comparison of andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer Jolyon P. Mitchell, Mark Nagel, Kimberly J. Wiersema, AAPS PharmSciTech EngineeringAerosol FormationLung DepositionAerospace EngineeringModel 3321	2003	102
Particle Size Analysis of Aerosols from Medicinal Inhalers Jolyon P. Mitchell, Mark Nagel KONA Powder and Particle Journal AsthmaParticle Size DistributionMeasurementAir QualityAerosol Sampling	2004	71
PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral Therapy Elena Bekerman, Joseph Hesselgesser, Brian Carr, Antimicrobial Agents and Chemotherapy Persistent Viral ReservoirAntiretroviral TherapyPd-1 BlockadeHuman RetrovirusImmunology	2019	59
Time-of-Flight Aerodynamic Particle Size Analyzers: Their Use and Limitations for the Evaluation of Medical Aerosols Jolyon P. Mitchell, Mark Nagel Journal of Aerosol Medicine EngineeringMeasurementAerosol AnalyzersFluid MechanicsAir Quality	1999	58
Electrostatics and inhaled medications: influence on delivery via pressurized metered-dose inhalers and add-on devices. Jolyon P. Mitchell, Dominic Coppolo, Mark Nagel PubMed ElectrohydrodynamicsEngineeringBiomedical EngineeringMetered-dose InhalersAdd-on Devices	2007	51
<i>In Vitro</i> Performance Testing of Three Small Volume-Holding Chambers under Conditions That Correspond with Use by Infants and Small Children Jolyon P. Mitchell, Mark Nagel Journal of Aerosol Medicine	1997	43
The Abbreviated Impactor Measurement (AIM) Concept: Part 1—Influence of Particle Bounce and Re-Entrainment—Evaluation with a “Dry” Pressurized Metered Dose Inhaler (pMDI)-Based Formulation Jolyon P. Mitchell, Mark Nagel, V. Avvakoumova, AAPS PharmSciTech Part 1—InfluenceLung DepositionMeasurementParticle BounceEducation	2009	36
Comparison of Three Valved Holding Chambers for the Delivery of Fluticasone Propionate–HFA to an Infant Face Model Emily Louca, Kitty Leung, Allan L. Coates, Journal of Aerosol Medicine	2006	34

Page 1